COVID-19 Outbreak-Global Cancer/Tumor Profiling Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Table of Content
1 Cancer/Tumor Profiling Introduction and Market Overview
- 1.1 Objectives of the Study
- 1.2 Overview of Cancer/Tumor Profiling
- 1.3 Scope of The Study
- 1.3.1 Key Market Segments
- 1.3.2 Players Covered
- 1.3.3 COVID-19's impact on the Cancer/Tumor Profiling industry
- 1.4 Methodology of The Study
- 1.5 Research Data Source
2 Executive Summary
- 2.1 Market Overview
- 2.1.1 Global Cancer/Tumor Profiling Market Size, 2015 – 2020
- 2.1.2 Global Cancer/Tumor Profiling Market Size by Type, 2015 – 2020
- 2.1.3 Global Cancer/Tumor Profiling Market Size by Application, 2015 – 2020
- 2.1.4 Global Cancer/Tumor Profiling Market Size by Region, 2015 - 2025
- 2.2 Business Environment Analysis
- 2.2.1 Global COVID-19 Status and Economic Overview
- 2.2.2 Influence of COVID-19 Outbreak on Cancer/Tumor Profiling Industry Development
3 Industry Chain Analysis
- 3.1 Upstream Raw Material Suppliers of Cancer/Tumor Profiling Analysis
- 3.2 Major Players of Cancer/Tumor Profiling
- 3.3 Cancer/Tumor Profiling Manufacturing Cost Structure Analysis
- 3.3.1 Production Process Analysis
- 3.3.2 Manufacturing Cost Structure of Cancer/Tumor Profiling
- 3.3.3 Labor Cost of Cancer/Tumor Profiling
- 3.4 Market Distributors of Cancer/Tumor Profiling
- 3.5 Major Downstream Buyers of Cancer/Tumor Profiling Analysis
- 3.6 The Impact of Covid-19 From the Perspective of Industry Chain
- 3.7 Regional Import and Export Controls Will Exist for a Long Time
- 3.8 Continued downward PMI Spreads Globally
4 Global Cancer/Tumor Profiling Market, by Type
- 4.1 Global Cancer/Tumor Profiling Value and Market Share by Type (2015-2020)
- 4.2 Global Cancer/Tumor Profiling Production and Market Share by Type (2015-2020)
- 4.3 Global Cancer/Tumor Profiling Value and Growth Rate by Type (2015-2020)
- 4.3.1 Global Cancer/Tumor Profiling Value and Growth Rate of Next-generation Sequencing
- 4.3.2 Global Cancer/Tumor Profiling Value and Growth Rate of In Situ Hybridization
- 4.3.3 Global Cancer/Tumor Profiling Value and Growth Rate of Immunohistochemistry
- 4.3.4 Global Cancer/Tumor Profiling Value and Growth Rate of Quantitative PCR
- 4.4 Global Cancer/Tumor Profiling Price Analysis by Type (2015-2020)
5 Cancer/Tumor Profiling Market, by Application
- 5.1 Downstream Market Overview
- 5.2 Global Cancer/Tumor Profiling Consumption and Market Share by Application (2015-2020)
- 5.3 Global Cancer/Tumor Profiling Consumption and Growth Rate by Application (2015-2020)
- 5.3.1 Global Cancer/Tumor Profiling Consumption and Growth Rate of Personalized Medicine (2015-2020)
- 5.3.2 Global Cancer/Tumor Profiling Consumption and Growth Rate of Biomarker Discovery (2015-2020)
- 5.3.3 Global Cancer/Tumor Profiling Consumption and Growth Rate of Diagnostics (2015-2020)
- 5.3.4 Global Cancer/Tumor Profiling Consumption and Growth Rate of Prognostics (2015-2020)
6 Global Cancer/Tumor Profiling Market Analysis by Regions
- 6.1 Global Cancer/Tumor Profiling Sales, Revenue and Market Share by Regions
- 6.1.1 Global Cancer/Tumor Profiling Sales by Regions (2015-2020)
- 6.1.2 Global Cancer/Tumor Profiling Revenue by Regions (2015-2020)
- 6.2 North America Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 6.3 Europe Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 6.4 Asia-Pacific Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 6.5 Middle East and Africa Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 6.6 South America Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
7 North America Cancer/Tumor Profiling Market Analysis by Countries
- 7.1 The Influence of COVID-19 on North America Market
- 7.2 North America Cancer/Tumor Profiling Sales, Revenue and Market Share by Countries
- 7.2.1 North America Cancer/Tumor Profiling Sales by Countries (2015-2020)
- 7.2.2 North America Cancer/Tumor Profiling Revenue by Countries (2015-2020)
- 7.3 United States Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 7.4 Canada Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 7.5 Mexico Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
8 Europe Cancer/Tumor Profiling Market Analysis by Countries
- 8.1 The Influence of COVID-19 on Europe Market
- 8.2 Europe Cancer/Tumor Profiling Sales, Revenue and Market Share by Countries
- 8.2.1 Europe Cancer/Tumor Profiling Sales by Countries (2015-2020)
- 8.2.2 Europe Cancer/Tumor Profiling Revenue by Countries (2015-2020)
- 8.3 Germany Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 8.4 UK Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 8.5 France Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 8.6 Italy Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 8.7 Spain Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 8.8 Russia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
9 Asia Pacific Cancer/Tumor Profiling Market Analysis by Countries
- 9.1 The Influence of COVID-19 on Asia Pacific Market
- 9.2 Asia Pacific Cancer/Tumor Profiling Sales, Revenue and Market Share by Countries
- 9.2.1 Asia Pacific Cancer/Tumor Profiling Sales by Countries (2015-2020)
- 9.2.2 Asia Pacific Cancer/Tumor Profiling Revenue by Countries (2015-2020)
- 9.3 China Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 9.4 Japan Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 9.5 South Korea Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 9.6 India Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 9.7 Southeast Asia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 9.8 Australia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
10 Middle East and Africa Cancer/Tumor Profiling Market Analysis by Countries
- 10.1 The Influence of COVID-19 on Middle East and Africa Market
- 10.2 Middle East and Africa Cancer/Tumor Profiling Sales, Revenue and Market Share by Countries
- 10.2.1 Middle East and Africa Cancer/Tumor Profiling Sales by Countries (2015-2020)
- 10.2.2 Middle East and Africa Cancer/Tumor Profiling Revenue by Countries (2015-2020)
- 10.3 Saudi Arabia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 10.4 UAE Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 10.5 Egypt Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 10.6 Nigeria Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 10.7 South Africa Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
11 South America Cancer/Tumor Profiling Market Analysis by Countries
- 11.1 The Influence of COVID-19 on Middle East and Africa Market
- 11.2 South America Cancer/Tumor Profiling Sales, Revenue and Market Share by Countries
- 11.2.1 South America Cancer/Tumor Profiling Sales by Countries (2015-2020)
- 11.2.2 South America Cancer/Tumor Profiling Revenue by Countries (2015-2020)
- 11.3 Brazil Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 11.4 Argentina Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 11.5 Columbia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
- 11.6 Chile Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
12 Competitive Landscape
- 12.1 Illumina Inc. (U.S.)
- 12.1.1 Illumina Inc. (U.S.) Basic Information
- 12.1.2 Cancer/Tumor Profiling Product Introduction
- 12.1.3 Illumina Inc. (U.S.) Production, Value, Price, Gross Margin 2015-2020
- 12.2 NeoGenomics Laboratories (U.S.)
- 12.2.1 NeoGenomics Laboratories (U.S.) Basic Information
- 12.2.2 Cancer/Tumor Profiling Product Introduction
- 12.2.3 NeoGenomics Laboratories (U.S.) Production, Value, Price, Gross Margin 2015-2020
- 12.3 QIAGEN N.V. (Netherlands)
- 12.3.1 QIAGEN N.V. (Netherlands) Basic Information
- 12.3.2 Cancer/Tumor Profiling Product Introduction
- 12.3.3 QIAGEN N.V. (Netherlands) Production, Value, Price, Gross Margin 2015-2020
- 12.4 HTG Molecular Diagnostic (U.S.)
- 12.4.1 HTG Molecular Diagnostic (U.S.) Basic Information
- 12.4.2 Cancer/Tumor Profiling Product Introduction
- 12.4.3 HTG Molecular Diagnostic (U.S.) Production, Value, Price, Gross Margin 2015-2020
- 12.5 Genomic Health Inc. (U.S.)
- 12.5.1 Genomic Health Inc. (U.S.) Basic Information
- 12.5.2 Cancer/Tumor Profiling Product Introduction
- 12.5.3 Genomic Health Inc. (U.S.) Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
- 13.1 Market Driver Analysis
- 13.1.2 Market Restraints Analysis
- 13.1.3 Market Trends Analysis
- 13.2 Merger, Acquisition and New Investment
- 13.3 News of Product Release
14 Global Cancer/Tumor Profiling Market Forecast
- 14.1 Global Cancer/Tumor Profiling Market Value & Volume Forecast, by Type (2020-2025)
- 14.1.1 Next-generation Sequencing Market Value and Volume Forecast (2020-2025)
- 14.1.2 In Situ Hybridization Market Value and Volume Forecast (2020-2025)
- 14.1.3 Immunohistochemistry Market Value and Volume Forecast (2020-2025)
- 14.1.4 Quantitative PCR Market Value and Volume Forecast (2020-2025)
- 14.2 Global Cancer/Tumor Profiling Market Value & Volume Forecast, by Application (2020-2025)
- 14.2.1 Personalized Medicine Market Value and Volume Forecast (2020-2025)
- 14.2.2 Biomarker Discovery Market Value and Volume Forecast (2020-2025)
- 14.2.3 Diagnostics Market Value and Volume Forecast (2020-2025)
- 14.2.4 Prognostics Market Value and Volume Forecast (2020-2025)
- 14.3 Cancer/Tumor Profiling Market Analysis and Forecast by Region
- 14.3.1 North America Market Value and Consumption Forecast (2020-2025)
- 14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
- 14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
- 14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
- 14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
- 15.1 Industry Barriers and New Entrants SWOT Analysis
- 15.1.1 Porter’s Five Forces Analysis
- 15.1.2 New Entrants SWOT Analysis
- 15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Cancer/Tumor Profiling
Table Product Specification of Cancer/Tumor Profiling
Table Cancer/Tumor Profiling Key Market Segments
Table Key Players Cancer/Tumor Profiling Covered
Figure Global Cancer/Tumor Profiling Market Size, 2015 – 2025
Table Different Types of Cancer/Tumor Profiling
Figure Global Cancer/Tumor Profiling Value ($) Segment by Type from 2015-2020
Figure Global Cancer/Tumor Profiling Market Share by Types in 2019
Table Different Applications of Cancer/Tumor Profiling
Figure Global Cancer/Tumor Profiling Value ($) Segment by Applications from 2015-2020
Figure Global Cancer/Tumor Profiling Market Share by Applications in 2019
Figure Global Cancer/Tumor Profiling Market Share by Regions in 2019
Figure North America Cancer/Tumor Profiling Production Value ($) and Growth Rate (2015-2020)
Figure Europe Cancer/Tumor Profiling Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Cancer/Tumor Profiling Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Cancer/Tumor Profiling Production Value ($) and Growth Rate (2015-2020)
Figure South America Cancer/Tumor Profiling Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Cancer/Tumor Profiling
Table Upstream Raw Material Suppliers of Cancer/Tumor Profiling with Contact Information
Table Major Players Headquarters, and Service Area of Cancer/Tumor Profiling
Figure Major Players Production Value Market Share of Cancer/Tumor Profiling in 2019
Table Major Players Cancer/Tumor Profiling Product Types in 2019
Figure Production Process of Cancer/Tumor Profiling
Figure Manufacturing Cost Structure of Cancer/Tumor Profiling
Figure Channel Status of Cancer/Tumor Profiling
Table Major Distributors of Cancer/Tumor Profiling with Contact Information
Table Major Downstream Buyers of Cancer/Tumor Profiling with Contact Information
Table Global Cancer/Tumor Profiling Value ($) by Type (2015-2020)
Table Global Cancer/Tumor Profiling Value Share by Type (2015-2020)
Figure Global Cancer/Tumor Profiling Value Share by Type (2015-2020)
Table Global Cancer/Tumor Profiling Production by Type (2015-2020)
Table Global Cancer/Tumor Profiling Production Share by Type (2015-2020)
Figure Global Cancer/Tumor Profiling Production Share by Type (2015-2020)
Figure Global Cancer/Tumor Profiling Value ($) and Growth Rate of Next-generation Sequencing (2015-2020)
Figure Global Cancer/Tumor Profiling Value ($) and Growth Rate of In Situ Hybridization (2015-2020)
Figure Global Cancer/Tumor Profiling Value ($) and Growth Rate of Immunohistochemistry (2015-2020)
Figure Global Cancer/Tumor Profiling Value ($) and Growth Rate of Quantitative PCR (2015-2020)
Figure Global Cancer/Tumor Profiling Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Cancer/Tumor Profiling Consumption by Application (2015-2020)
Table Global Cancer/Tumor Profiling Consumption Market Share by Application (2015-2020)
Figure Global Cancer/Tumor Profiling Consumption Market Share by Application (2015-2020)
Figure Global Cancer/Tumor Profiling Consumption and Growth Rate of Personalized Medicine (2015-2020)
Figure Global Cancer/Tumor Profiling Consumption and Growth Rate of Biomarker Discovery (2015-2020)
Figure Global Cancer/Tumor Profiling Consumption and Growth Rate of Diagnostics (2015-2020)
Figure Global Cancer/Tumor Profiling Consumption and Growth Rate of Prognostics (2015-2020)
Figure Global Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure Global Cancer/Tumor Profiling Revenue (M USD) and Growth (2015-2020)
Table Global Cancer/Tumor Profiling Sales by Regions (2015-2020)
Table Global Cancer/Tumor Profiling Sales Market Share by Regions (2015-2020)
Table Global Cancer/Tumor Profiling Revenue (M USD) by Regions (2015-2020)
Table Global Cancer/Tumor Profiling Revenue Market Share by Regions (2015-2020)
Table Global Cancer/Tumor Profiling Revenue Market Share by Regions in 2015
Table Global Cancer/Tumor Profiling Revenue Market Share by Regions in 2019
Figure North America Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure Europe Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure South America Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Cancer/Tumor Profiling Revenue (M USD) and Growth (2015-2020)
Table North America Cancer/Tumor Profiling Sales by Countries (2015-2020)
Table North America Cancer/Tumor Profiling Sales Market Share by Countries (2015-2020)
Table North America Cancer/Tumor Profiling Revenue (M USD) by Countries (2015-2020)
Table North America Cancer/Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure United States Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure Canada Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure Mexico Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Cancer/Tumor Profiling Revenue (M USD) and Growth (2015-2020)
Table Europe Cancer/Tumor Profiling Sales by Countries (2015-2020)
Table Europe Cancer/Tumor Profiling Sales Market Share by Countries (2015-2020)
Table Europe Cancer/Tumor Profiling Revenue (M USD) by Countries (2015-2020)
Table Europe Cancer/Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure Germany Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure UK Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure France Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Italy Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Spain Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Russia Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Cancer/Tumor Profiling Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Cancer/Tumor Profiling Sales by Countries (2015-2020)
Table Asia Pacific Cancer/Tumor Profiling Sales Market Share by Countries (2015-2020)
Table Asia Pacific Cancer/Tumor Profiling Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Cancer/Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure China Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure Japan Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure South Korea Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure India Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Southeast Asia Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Australia Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Middle East Cancer/Tumor Profiling Revenue (M USD) and Growth (2015-2020)
Table Middle East Cancer/Tumor Profiling Sales by Countries (2015-2020)
Table Middle East and Africa Cancer/Tumor Profiling Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Cancer/Tumor Profiling Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Cancer/Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure UAE Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure Egypt Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Nigeria Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure South Africa Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure South America Cancer/Tumor Profiling Revenue (M USD) and Growth (2015-2020)
Table South America Cancer/Tumor Profiling Sales by Countries (2015-2020)
Table South America Cancer/Tumor Profiling Sales Market Share by Countries (2015-2020)
Table South America Cancer/Tumor Profiling Revenue (M USD) by Countries (2015-2020)
Table South America Cancer/Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure Brazil Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure Argentina Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
Figure Columbia Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Chile Cancer/Tumor Profiling Sales and Growth (2015-2020)
Figure Top 3 Market Share of Cancer/Tumor Profiling Companies in 2019
Figure Top 6 Market Share of Cancer/Tumor Profiling Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Illumina Inc. (U.S.) Profile
Table Illumina Inc. (U.S.) Product Introduction
Figure Illumina Inc. (U.S.) Production and Growth Rate
Figure Illumina Inc. (U.S.) Value ($) Market Share 2015-2020
Table NeoGenomics Laboratories (U.S.) Profile
Table NeoGenomics Laboratories (U.S.) Product Introduction
Figure NeoGenomics Laboratories (U.S.) Production and Growth Rate
Figure NeoGenomics Laboratories (U.S.) Value ($) Market Share 2015-2020
Table QIAGEN N.V. (Netherlands) Profile
Table QIAGEN N.V. (Netherlands) Product Introduction
Figure QIAGEN N.V. (Netherlands) Production and Growth Rate
Figure QIAGEN N.V. (Netherlands) Value ($) Market Share 2015-2020
Table HTG Molecular Diagnostic (U.S.) Profile
Table HTG Molecular Diagnostic (U.S.) Product Introduction
Figure HTG Molecular Diagnostic (U.S.) Production and Growth Rate
Figure HTG Molecular Diagnostic (U.S.) Value ($) Market Share 2015-2020
Table Genomic Health Inc. (U.S.) Profile
Table Genomic Health Inc. (U.S.) Product Introduction
Figure Genomic Health Inc. (U.S.) Production and Growth Rate
Figure Genomic Health Inc. (U.S.) Value ($) Market Share 2015-2020
Table Market Driving Factors of Cancer/Tumor Profiling
Table Merger, Acquisition and New Investment
Table Global Cancer/Tumor Profiling Market Value ($) Forecast, by Type
Table Global Cancer/Tumor Profiling Market Volume Forecast, by Type
Figure Global Cancer/Tumor Profiling Market Value ($) and Growth Rate Forecast of Next-generation Sequencing (2020-2025)
Figure Global Cancer/Tumor Profiling Market Volume ($) and Growth Rate Forecast of Next-generation Sequencing (2020-2025)
Figure Global Cancer/Tumor Profiling Market Value ($) and Growth Rate Forecast of In Situ Hybridization (2020-2025)
Figure Global Cancer/Tumor Profiling Market Volume ($) and Growth Rate Forecast of In Situ Hybridization (2020-2025)
Figure Global Cancer/Tumor Profiling Market Value ($) and Growth Rate Forecast of Immunohistochemistry (2020-2025)
Figure Global Cancer/Tumor Profiling Market Volume ($) and Growth Rate Forecast of Immunohistochemistry (2020-2025)
Figure Global Cancer/Tumor Profiling Market Value ($) and Growth Rate Forecast of Quantitative PCR (2020-2025)
Figure Global Cancer/Tumor Profiling Market Volume ($) and Growth Rate Forecast of Quantitative PCR (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Personalized Medicine (2020-2025)
Figure Market Volume and Growth Rate Forecast of Personalized Medicine (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Biomarker Discovery (2020-2025)
Figure Market Volume and Growth Rate Forecast of Biomarker Discovery (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Diagnostics (2020-2025)
Figure Market Volume and Growth Rate Forecast of Diagnostics (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Prognostics (2020-2025)
Figure Market Volume and Growth Rate Forecast of Prognostics (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
The Cancer/Tumor Profiling market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Cancer/Tumor Profiling industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Cancer/Tumor Profiling market can be split based on product types, major applications, and important countries as follows:
Key players in the global Cancer/Tumor Profiling market covered in Chapter 12:
Illumina Inc. (U.S.)
NeoGenomics Laboratories (U.S.)
QIAGEN N.V. (Netherlands)
HTG Molecular Diagnostic (U.S.)
Genomic Health Inc. (U.S.)
In Chapter 4 and 14.1, on the basis of types, the Cancer/Tumor Profiling market from 2015 to 2025 is primarily split into:
Next-generation Sequencing
In Situ Hybridization
Immunohistochemistry
Quantitative PCR
In Chapter 5 and 14.2, on the basis of applications, the Cancer/Tumor Profiling market from 2015 to 2025 covers:
Personalized Medicine
Biomarker Discovery
Diagnostics
Prognostics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025